Literature DB >> 30074617

Artificial Sphincters to Manage Urinary Incontinence: A Review.

Leonardo Marziale1, Gioia Lucarini1, Tommaso Mazzocchi1, Emanuele Gruppioni2, Simona Castellano2, Angelo Davalli2, Rinaldo Sacchetti2, Donatella Pistolesi3, Leonardo Ricotti1, Arianna Menciassi1.   

Abstract

Urinary incontinence affects more than 300 million people worldwide. The implantation of a medical device called an artificial urinary sphincter (AUS) is the gold standard treatment when conservative and minimally invasive therapies fail. In this article, the AUSs (extra-urethral and endo-urethral sphincters) available on the market, both presented at the research level and filed as patents, are reviewed. The ability of the different solutions to effectively replace the natural sphincter are discussed, together with advantages and some possible side effects, such as tissue atrophy, overall invasiveness of the implant, and so forth. Finally, future research priorities are discussed for both endo-urethral and extra-urethral approaches considering key engineering aspects, such as materials, compression and closure mechanisms, and implantation methods, with the long-term aim of developing an effective, reliable, durable, and minimally invasive AUS capable of restoring a normal quality of life for incontinent patients.
© 2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  Artificial sphincter; Endo-urethral system; Extra-urethral system; Magnetic mechanism; Mechatronic system; Medical device; Urinary incontinence

Mesh:

Year:  2018        PMID: 30074617     DOI: 10.1111/aor.13164

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  1 in total

1.  PDMS and DLC-coated unidirectional valves for artificial urinary sphincters: Opening performance after 126 days of immersion in urine.

Authors:  Tommaso Mazzocchi; Gioia Lucarini; Irene Roehrer; Arianna Menciassi; Leonardo Ricotti
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2021-11-02       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.